kras mutation and glutathion glutathione pancreatic cancer How survives ferroptosis? Pancreatic ductal adenocarcinoma (PDAC) tumors harboring mutations exhibit KRAS G12D: The Next Frontier
KRAS G12D: The Next Frontier in Cancer Therapy MedChemExpress Rerouting the drug response: Overcoming metabolic adaptation in KRAS mutant cancers Science Signaling Promising direction for the treatment of pancreatic cancers driven by KRAS mutation Der Lab KRAS targeted therapies in cancer: novel approaches and overcoming resistance BMJ Oncology Frontiers Targeting KRAS: The Elephant in the Room of Epithelial Cancers
Pay in 4 interest-free payments of $6.37 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7




